Evidence map›Paper›PMID 41779177›Full record

ArticleMolecular genetics and genomics : MGG2026

New variant in KITLG shapes the pathogenesis of familial progressive hyper- and hypo-pigmentation.

Bodan Wu, Ming He, Tongyun Liu, Wenjing Zhao, Jianhong Ye, Tao Jiang, Congcong Teng, Yaxin Huang, Yangjia Zhang, Jiao Li and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bodan Wu *Department of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Ming He *Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Science, Kunming Medical University, Kunming, 650500, China.
Tongyun Liu *Department of Skin, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Wenjing ZhaoDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Jianhong YeDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Tao JiangDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Congcong TengDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Yaxin HuangDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Yangjia ZhangDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Jiao LiDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.
Hong ShiState Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China. shih@kust.edu.cn.ORCID http://orcid.org/0000-0003-0495-447X
Jie ZhangDepartment of Medical Genetics, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. kmzhjie@aliyun.com.

Funding

Famous doctor project Yunnan Province YNWR-MY-2020-066Young and middle-aged academic and technical leaders of Yunnan Province 202105AC160034
6 · The paper itself

Abstract

Familial progressive hyper- and hypo-pigmentation (FPHH) is a pigmentary disorder characterized by a mixture of hypo- and hyper-pigmentation lesions, brown spots, and hypo-pigmentation gray leaf spots. This disease had previously been reported to be associated with the KITLG gene. In this study, whole exome sequencing was performed to identify the gene mutation in two patients suspected with FPHH. Functional changes were explored at a cellular level with the help of adenine base editors, and the differentially expressed genes in the melanin pathway were detected through RNA-sequencing. Mutations were identified in two patients at exon 4 of KITLG (NM_000899.4): [c.329 A > T] and [c.329 A > G]. The c.329 A > G is a de novo mutation. The two variations were located in a conservative region and were predicted to be likely pathogenic mutations. For de novo c.329 A > G mutation, results showed that the mutation broadly affected the transcription and translation of genes responsible for melanin synthesis, especially the melanin gene MITF. These results indicated that the conservative locus c.329 A had an important function to KITLG, mutations [c.329 A > T] and [c.329 A > G] in KITLG could result FPHH. Based on the functional tests, c.329 A > G could be pathogenic mutant. This study has an important clinical significance, and it would extend the mutation spectrum of KITLG gene. It would improve the disease knowledge base and offer a reliable reference for the clinical diagnosis and prevention of FPHH.

Indexed as

HyperpigmentationHypopigmentationStem Cell FactorExome SequencingExonsFemaleHumansMelaninsMicrophthalmia-Associated Transcription FactorMutationPedigreeKITLG protein, humanMelaninsMicrophthalmia-Associated Transcription FactorStem Cell FactorDe novo mutationFamilial progressive hyperpigmentation and hypopigmentationKITLG geneSingle-base editingSkin pigmentation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.